These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1908381)

  • 61. Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets.
    Mendes RE; Castanheira M; Woosley LN; Stone GG; Bradford PA; Flamm RK
    Int J Antimicrob Agents; 2018 Aug; 52(2):287-292. PubMed ID: 29654893
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antiseptic and antibiotic resistance in Gram-negative bacteria causing urinary tract infection.
    Stickler DJ; Thomas B
    J Clin Pathol; 1980 Mar; 33(3):288-96. PubMed ID: 6769972
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.
    Tantisiriwat W; Linasmita P
    J Med Assoc Thai; 2017 Apr; 100(4):469-78. PubMed ID: 29912484
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora.
    Richard P; Delangle MH; Raffi F; Espaze E; Richet H
    Clin Infect Dis; 2001 Jan; 32(1):162-6. PubMed ID: 11112677
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antimicrobial susceptibilities of blood culture isolates obtained before and after the introduction of ciprofloxacin.
    Pieroni P; Goodfellow J; Reesor L; Louie M; Simor AE
    J Antimicrob Chemother; 1997 Mar; 39(3):419-22. PubMed ID: 9096194
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Pattern of antimicrobial susceptibility in uropathogen isolates from children].
    Suárez VM; Suárez RC; Pérez BA; Alvarez FA; Castro SP; Rodríguez FS; Guerrero SM
    Rev Esp Quimioter; 2001 Mar; 14(1):63-8. PubMed ID: 11376352
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of swarming in the formation of crystalline Proteus mirabilis biofilms on urinary catheters.
    Jones BV; Mahenthiralingam E; Sabbuba NA; Stickler DJ
    J Med Microbiol; 2005 Sep; 54(Pt 9):807-813. PubMed ID: 16091430
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drug resistance of urinary tract pathogens cultured from ambulatory patients in the community in 1969.
    Bauer AW
    J Urol; 1971 Nov; 106(5):750-6. PubMed ID: 5000524
    [No Abstract]   [Full Text] [Related]  

  • 69. [Compared studies of antimicrobial agents against E. coli, Klebsiella, Citrobacter and Proteus isolated from urinary tract infections].
    Kosakai N; Igari J; Kumamoto Y; Sakai S; Nishio A; Nagai T; Shigeta S; Shiraiwa Y; Abe K; Tazaki H; Iri H; Uchida H; Ando Y; Furuya H; Matsuda S; Soeda N; Yokomatsu M; Oguri T; Furusawa T; Takeuchi Y; Tsuchida H; Yamashita N; Okamoto Y; Shimoe S; Kamiki T; Nasu M; Yamaguchi K
    Jpn J Antibiot; 1982 Apr; 35(4):1022-44. PubMed ID: 7047795
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
    Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bacterial biofilms in patients with indwelling urinary catheters.
    Stickler DJ
    Nat Clin Pract Urol; 2008 Nov; 5(11):598-608. PubMed ID: 18852707
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effect of EDTA instillations on the rate of development of encrustation and biofilms in Foley catheters.
    Percival SL; Sabbuba NA; Kite P; Stickler DJ
    Urol Res; 2009 Aug; 37(4):205-9. PubMed ID: 19468723
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Microbial resistance to antibiotics used to treat urinary tract infections in Mexican children.
    Hernández-Porras M; Salmerón-Arteaga G; Medina-Santillán R
    Proc West Pharmacol Soc; 2004; 47():120-1. PubMed ID: 15633630
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.
    Jacobsen SM; Stickler DJ; Mobley HL; Shirtliff ME
    Clin Microbiol Rev; 2008 Jan; 21(1):26-59. PubMed ID: 18202436
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An In Vitro Bladder Model for Studying Catheter-Associated Urinary Tract Infection and Associated Analysis of Biofilms.
    Nzakizwanayo J; Pelling H; Milo S; Jones BV
    Methods Mol Biol; 2019; 2021():139-158. PubMed ID: 31309503
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). II. Background of patients].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Mochida C
    Jpn J Antibiot; 1997 Mar; 50(3):251-64. PubMed ID: 9575354
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
    Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
    Brothers AM; Gibbs PS; Wooley RE
    Vet Ther; 2002; 3(4):493-500. PubMed ID: 12584687
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pseudomonas aeruginosa and long-term indwelling bladder catheters.
    Stickler DJ; Clayton CL; Harber MJ; Chawla JC
    Arch Phys Med Rehabil; 1988 Jan; 69(1):25-8. PubMed ID: 3122709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.